Conmed (CNMD) Change in Accured Expenses (2010 - 2026)

Conmed has reported Change in Accured Expenses for 17 years, with the latest figure at -$21.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 310.54% year-over-year to -$21.2 million; the trailing twelve-month figure through Mar 2026 stood at -$25.0 million (down 192.47% YoY), and the FY2025 full-year result was $6.2 million, up 318.56% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$21.2 million, down from -$2.8 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $18.6 million in Q4 2023, with the low at -$21.2 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$725647.1 across 5 years, with a median of $3.9 million in 2023.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 690.86% — and 2023, when it soared 2726.45%.
• Conmed's Change in Accured Expenses stood at -$707000.0 in 2022, then soared by 2726.45% to $18.6 million in 2023, then slumped by 71.84% to $5.2 million in 2024, then slumped by 153.47% to -$2.8 million in 2025, then slumped by 656.55% to -$21.2 million in 2026.
• The last three Change in Accured Expenses figures came in at -$21.2 million (Q1 2026), -$2.8 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.